- Home
- MVST vs XBIT Comparison
MVST vs XBIT Comparison
Compare MVST & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVST | XBIT |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Pharmaceuticals and Biotechnology |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 987.8M | 71.3M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | MVST | XBIT |
|---|---|---|
| Price | $1.58 | $2.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | 44.4K |
| Earning Date | 03-16-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.85 | N/A |
| Revenue Next Year | $36.59 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.09 | $2.09 |
| 52 Week High | $7.12 | $3.62 |
Technical Indicators
Market Signals| Indicator | MVST | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 33.62 | 50.66 |
| Support Level | $1.51 | $2.32 |
| Resistance Level | $2.49 | $2.49 |
| Average True Range (ATR) | 0.15 | 0.09 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 7.08 | 60.32 |
Price Performance
Historical ComparisonAbout MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.